Literature DB >> 28474985

Prevalence and extent of right-to-left shunt on contrast-enhanced transcranial Doppler in Chinese patients with migraine in a multicentre case-control study.

Si-Bo Wang1, Kang-Ding Liu1, Yi Yang1, Ya-Jie Li2, Ming-Yi Hu3, Pan Lin4, Rong Guo5, Qian Tian6, Yong You7, Ying-Hua Cui8, Guan-Ling Zhang9, Zhao Dong10, Yong-Sheng Gao11, Ying-Qi Xing1.   

Abstract

Background The association between RLS and migraine is still debated. The aim of this study is to investigate the prevalence and grade of RLS in Chinese patients with migraine and to evaluate the relationship between RLS and migraine. Methods A multi-center case-control study of contrast-enhanced transcranial Doppler was conducted in 931 consecutive patients with migraine (240 of 931 had migraine with aura and 691 of 931 were in the migraine without aura group) and 282 were healthy adults. Clinical trial no. NCT02425696. Results The prevalence of RLS was 63.8% and 39.9% in the migraine with aura group (MA+) and migraine without aura group (MA-), respectively, significantly higher than that of the healthy group (29.4%, p < 0.001; p < 0.001). The positive rate of large RLS in the MA+ group and MA- group was 32.1% and 16.5%, respectively, significantly higher than healthy group (6.4%, p < 0.001; p < 0.001). There was no difference among groups in terms of positive rate of permanent RLS ( p = 0.704). Conclusion This multi-centre case-control study suggested that there is an association between RLS and migraine with and without aura, especially when the shunt is large.

Entities:  

Keywords:  Right-to-left shunt; migraine; patent foramen ovale; transcranial Doppler

Mesh:

Year:  2017        PMID: 28474985     DOI: 10.1177/0333102417708203

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  8 in total

1.  Association between patent foramen ovale and migraine without aura: a community-based cross-sectional study in China.

Authors:  Yusha Tang; Anjiao Peng; Bo Peng; Shixu He; Xia Zhao; Yuanfeng Zhu; Wanlin Lai; Tingting Song; Lei Chen
Journal:  BMJ Open       Date:  2022-03-31       Impact factor: 2.692

2.  Analysis of the characteristics of sleep in patients with patent foramen ovale complicated with obstructive sleep apnea.

Authors:  Xiaonan Li; Chunling Liu; Jun Wu; Yanlu Jia; Hui Li; Haitao Yu; Zhitong Guan; Yimin Zhao; Shuning Sun
Journal:  Sleep Breath       Date:  2021-01-13       Impact factor: 2.816

3.  Clinical features of right-to-left shunt in the different subgroups of migraine.

Authors:  Yanyan Ling; Min Wang; Xudong Pan; Hongqin Zhao
Journal:  Brain Behav       Date:  2020-02-03       Impact factor: 2.708

4.  Transcatheter Patent Foramen Ovale Closure Is Effective in Alleviating Migraine in a 5-Year Follow-Up.

Authors:  Yao-De He; Xiu-Li Yan; Chen Qin; Peng Zhang; Zhen-Ni Guo; Yi Yang
Journal:  Front Neurol       Date:  2019-11-19       Impact factor: 4.003

5.  Prevalence and grade of RLS in migraine: A prospective study of 251 migraineurs by synchronous test of c-TTE and c-TCD.

Authors:  Qiuxia Zhao; Rong Liu; Jun Zhou; Zhizhi Dong; Yue Chen
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

6.  The Relationship Between Patent Foramen Ovale and Unexplained Dizziness: A Prospective Analysis in China.

Authors:  Qian Cao; Yu Shen; Zhuo Hou; Defu Li; Boji Tang; Lijun Xu; Yanping Li
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-26       Impact factor: 2.989

7.  Transcranial Doppler Ultrasound for Monitoring the Cerebral Hemodynamic Changes and Prognosticating Outcomes in Venoarterial Extracorporeal Membrane-Oxygenated Patients.

Authors:  Man Wang; Le Li; Yi-Dong Tan
Journal:  Int J Clin Pract       Date:  2022-08-22       Impact factor: 3.149

8.  Echocardiographic characteristics of transcatheter closure of patent foramen ovale with mallow biodegradable occluder: A single-center, phase III clinical study.

Authors:  Lin Song; Peixuan Shi; Xiaozhou Zheng; Li Hongxin; Ziang Li; Meng Lv; Haiyan Wang
Journal:  Front Cardiovasc Med       Date:  2022-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.